December 23, 2011 Allergan Reassures Patients and Surgeons of the Quality and Safety of Its Breast Implant Devices Sold and Distributed Worldwide

November 14, 2011 Health Canada approves BOTOX® as prophylactic treatment for chronic migraine

October 6, 2011 Award-winning Actress Courtney Thorne-Smith and Allergan, Inc. Reveal Changes in Women's Perceptions of BOTOX Cosmetic Over Nearly a Decade

September 21, 2011 National Headache Foundation, HealthyWomen and Allergan Offer People Living With Chronic Migraine a Chance to "Rewrite Your Day"

August 24, 2011 BOTOX®(onabotulinumtoxinA) Receives U.S. FDA Approval for the Treatment of Urinary Incontinence in Adults with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury

August 8, 2011 Allergan's BOTOX® Receives A Positive Opinion in Fourteen European Countries for Urinary Incontinence in Patients with MS or Spinal Cord Injury

August 8, 2011 Allergan's BOTOX® Receives A Positive Opinion in Fourteen European Countries for Urinary Incontinence in Patients with MS or Spinal Cord Injury

July 19, 2011 Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics

June 22, 2011 New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes

June 7, 2011 Christina Hendricks Kicks Off the Latisse® Wishes Challenge with the Goal of Raising $500,000 for the Make-A-Wish Foundation®

June 6, 2011 Allergan Launches Open Letter to Congress to Kick-Off the 2011 C.H.O.I.C.E. Campaign

May 4, 2011 Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases

April 13, 2011 New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions

March 7, 2011 Allergan Board of Directors Announces Departure of President F. Michael Ball; Chairman of the Board and Chief Executive Officer David E.I. Pyott Resumes Role as President

February 16, 2011 FDA Approves Expanded Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults

January 31, 2011 Allergan and MAP Pharmaceuticals Announce Collaboration on LEVADEX™ Investigational Therapy for Acute Migraine

December 3, 2010 FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults

November 25, 2010 New treatment targets natural tears for dry eyes

November 17, 2010 Discover the Power of the Lash

October 15, 2010 BOTOX® (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers

October 15, 2010 ADDING MULTIMEDIA BOTOX® (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers

September 24, 2010 Allergan Receives FDA Approval for OZURDEX® as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye

September 1, 2010 Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX®

August 31, 2010 Allergan, Inc. Receives FDA Approval for LUMIGAN® 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients

August 2, 2010 Allergan Reports Second Quarter 2010 Operating Results

July 9, 2010 BOTOX® Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine

July 2, 2010 Allergan Announces Quarterly Conference Call

June 15, 2010 Lifestyle Designer Kathy Ireland, Professional Ballroom Dancer Chelsie Hightower and Style Guide Bobbie Thomas Lead the LATISSE® Wishes Challenge Campaign to Benefit the Make-A-Wish Foundation®

June 7, 2010 Allergan Receives CEO Cancer Gold Standard(TM) Accreditation

May 19, 2010 Allergan Receives FDA Approval for ZYMAXID(TM) Ophthalmic Solution

May 13, 2010 Allergan, Inc. Launches Public Awareness and Advocacy Campaign to Urge Greater Attention to Critical Need for Both Prevention and Treatment to Effectively Address Adult Obesity

April 30, 2010 Allergan Reports First Quarter 2010 Operating Results

April 2, 2010 Allergan Announces Quarterly Conference Call

April 1, 2010 Allergan and Serenity Pharmaceuticals Enter into Global Agreement for the Treatment of Nocturia

March 25, 2010 BOTOX® Cosmetic Launches 'My Expressions of Kindness' Charitable Campaign to Raise Awareness and Support for Make It Right, Dress for Success and Children's Action Network

March 16, 2010 Allergan, Inc. Announces the JUVEDERM® 'Switch Up' Campaign Educating Women on the Positive Impact Small Changes Have on Personal Appearance

March 9, 2010 BOTOX® (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

March 3, 2010 Bristol-Myers Squibb and Allergan Enter Global Agreement on Investigational Neuropathic Pain Medicine

March 3, 2010 Allergan Celebrates 20 Years of Approved Use of Botulinum Toxin Type A (BOTOX®) in Canada

February 1, 2010 Allergan, Inc. Announces FDA Approval of JUVÉDERM(R) XC Dermal Filler Formulated with Lidocaine

Would you like to view all Allergan, Inc. press releases including the archive of previous years? Click here.